Donor Peripheral Blood Stem Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor Peripheral Blood Stem Cells, covering 2017-07-02 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Phase 2]